Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis

被引：0
|
作者：
Jörg Tamihardja
Max Schortmann
Ingulf Lawrenz
Stefan Weick
Klaus Bratengeier
Michael Flentje
Matthias Guckenberger
Bülent Polat
机构：
[1] University Hospital Wuerzburg,Department of Radiation Oncology
[2] University of Wuerzburg,Department of Radiation Oncology
[3] University Hospital Zurich,undefined
[4] University of Zurich,undefined
来源：
Strahlentherapie und Onkologie | 2021年 / 197卷
关键词：
Simultaneous integrated boost; Cone beam CT; Hypofractionation; Intensity-modulated radiation therapy; Image-guided radiation therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：124 / 132
页数：8
相关论文
共 50 条
  • [31] Hypofractionated Radiotherapy with or without IGRT in Prostate Cancer: Preliminary Report of Acute Toxicity
    Valeriani, Maurizio
    Monaco, Flavia
    Osti, Mattia Falchetto
    De Sanctis, Vitaliana
    Minniti, Giuseppe
    Enrici, Riccardo Maurizi
    ANTICANCER RESEARCH, 2011, 31 (10) : 3555 - 3558
  • [32] 3D-conformal hypofractionated radiotherapy for prostate cancer with daily transabdominal ultrasonography prostate localization: toxicity and outcome of a pilot study
    Zerini, Dario
    Jereczek-Fossa, Barbara Alicia
    Vavassori, Andrea
    Bossi-Zanetti, Isa
    Mauro, Roberta
    Ivaldi, Giovanni Battista
    Trovo, Marco
    Cambria, Raffaella
    Garibaldi, Cristina
    Cattani, Federica
    Orecchia, Roberto
    TUMORI JOURNAL, 2010, 96 (06): : 941 - 946
  • [33] Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome
    Barra, Salvina
    Belgioia, Liliana
    Marcenaro, Michela
    Callegari, Serena
    Pastorino, Alice
    Trapani, Luca
    Cavagnetto, Francesca
    Garelli, Stefania
    Corvo, Renzo
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 473 - 480
  • [34] Moderately hypofractionated dose escalation radiotherapy for localized prostate cancer, ESHYPRO: Results of a retrospective single-centre series evaluating safety and efficacy
    Quintin, K.
    Crehange, G.
    Graff, P.
    CANCER RADIOTHERAPIE, 2024, 28 (04): : 333 - 340
  • [35] Long-term clinical outcomes after 12-fractionated carbon-ion radiotherapy for localized prostate cancer
    Sato, Hiraku
    Kasuya, Goro
    Ishikawa, Hitoshi
    Nomoto, Akihiro
    Ono, Takashi
    Nakajima, Mio
    Isozaki, Yuka
    Yamamoto, Naoyoshi
    Iwai, Yuma
    Nemoto, Kenji
    Ichikawa, Tomohiko
    Tsuji, Hiroshi
    CANCER SCIENCE, 2021, 112 (09) : 3598 - 3606
  • [36] Long-term results of a study using individualized planning target volumes for hypofractionated intensity-modulated radiotherapy boost for prostate cancer
    Chu, William
    Loblaw, D. Andrew
    Chan, Kelvin
    Morton, Gerard
    Choo, Richard
    Szumacher, Ewa
    Danjoux, Cyril
    Pignol, Jean-Philippe
    Cheung, Patrick
    RADIATION ONCOLOGY, 2015, 10
  • [37] Long-term results of a study using individualized planning target volumes for hypofractionated intensity-modulated radiotherapy boost for prostate cancer
    William Chu
    D Andrew Loblaw
    Kelvin Chan
    Gerard Morton
    Richard Choo
    Ewa Szumacher
    Cyril Danjoux
    Jean-Philippe Pignol
    Patrick Cheung
    Radiation Oncology, 10
  • [38] Acute toxicity of image-guided hypofractionated proton therapy for localized prostate cancer
    Koichiro Nakajima
    Hiromitsu Iwata
    Hiroyuki Ogino
    Yukiko Hattori
    Shingo Hashimoto
    Mikiko Nakanishi
    Toshiyuki Toshito
    Yukihiro Umemoto
    Shoichiro Iwatsuki
    Yuta Shibamoto
    Jun-etsu Mizoe
    International Journal of Clinical Oncology, 2018, 23 : 353 - 360
  • [39] Acute toxicity of image-guided hypofractionated proton therapy for localized prostate cancer
    Nakajima, Koichiro
    Iwata, Hiromitsu
    Ogino, Hiroyuki
    Hattori, Yukiko
    Hashimoto, Shingo
    Nakanishi, Mikiko
    Toshito, Toshiyuki
    Umemoto, Yukihiro
    Iwatsuki, Shoichiro
    Shibamoto, Yuta
    Mizoe, Jun-etsu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (02) : 353 - 360
  • [40] Late Toxicity and Outcomes in High-risk Prostate Cancer Patients Treated With Hypofractionated IMRT and Long-term Androgen Suppression Treatment
    Pervez, Nadeem
    Boychak, Alex
    Drodge, Claudia S.
    Yee, Don
    Le, Duc
    Murtha, Albert
    Parliament, Matthew
    Amanie, John
    Mihai, Alina
    Field, Colin
    Mackenzie, Marc
    Ghosh, Sunita
    Fallone, Gino
    Pearcey, Robert
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (02): : 200 - 206
12345